Experts in a complete range of top treatments.
The Urologic Oncology Center at GBMC's Berman Cancer Institute provides a complete range of evaluation and treatment for urologic malignancies including kidney, prostate and bladder cancers.
GBMC's Radiation Oncology and Medical Oncology teams work in tandem with our urologists to provide urologic cancer care at the highest level of expertise. Our comprehensive capabilities include:
- The latest cryosurgical and laparoscopic surgery techniques
- Prostate surgery with state-of-the-art robotic technology allowing greater accuracy by physicians, less blood loss and scarring for patients, faster recoveries, and fewer complications
- Advanced radiation therapies targeting cancers with most maximum power and precision, while minimizing damage to surrounding tissue and organs
- The brachytherapy procedure for prostate cancer, implanting radioactive seeds to target tumors internally
New ultra-sensitive PSA test helps predict whether prostate cancer will return. Men who have had their cancerous prostate gland removed want to know if they are cured, but PSA tests have not been sensitive enough to provide a concrete answer. Now the new Ultrasensitive Nanoparticle PSA test detects PSA at levels in the blood that cannot be detected by conventional tests. This allows physicians to act at the earliest and most sensitive time, providing patients with the best chance of long-term survival.
Chief of Urology
Dr. Tutrone is board-certified in urology. He received his medical degree from Rutgers University Medical School, and completed his Urology residency at Harvard, Brigham & Women's Hospital . He also serves as the Medical Director for Chesapeake Urology Research Associates and is chairman of The William E Kahlert Urology Endowment. His clinical interests include treatment of urologic malignancies, laparoscopic treatment of renal and adrenal tumors, kidney stone treatment and prostate disorders.